Epidemiology and treatment of TB in London (UK) and New York (USA)
| London (current) | New York (1992–4) | |
|---|---|---|
| *Estimated as £6k per TB patient and £60k per MDRTB treated. | ||
| †Actually around 30% were receiving DOT. | ||
| ‡Unpublished data, North East London TB Network, London TB Group and King’s College Hospital, South East London. | ||
| §38% of all, 72% of those tested. | ||
| Incidence of TB | 35/100 000 (Newham 110/100 000) | 46 per 100/000 (Central Harlem 222/100 000) |
| Cost of TB services | £8 million14 (£34.2 million)15* | >$400 million2 |
| DOT strategy | Selective | Universal† |
| Completed treatment | 87%‡ | <50%2 |
| Relapsed TB | 6–8%‡ | 51%2 |
| HIV co-infection | 14%16 | 38%2§ |
| Multidrug resistant TB | 1.7%1 | 19%17 |
| Recent transmission (estimate from molecular epidemiology) | 14.4%3 | 48%4 |
| Cause of increase in TB | New entrants (foreign born), elderly women, HIV (11%)16 | HIV,2 nosocomial, homeless, foreign born |